nanocarri
drug
deliveri
system
ndd
paid
attent
convent
drug
deliveri
system
cancer
therapi
howev
efficaci
hamper
fast
clearanc
activ
macrophag
blood
circul
system
studi
glycyrrhizin
gl
introduc
algin
alg
nanogel
particl
ngp
construct
multifunct
deliveri
vehicl
decreas
fast
clearanc
activ
macrophag
enhanc
anticanc
efficaci
combin
therapi
gl
doxorubicin
dox
method
firstli
synthes
glalg
ngp
intermolecular
hydrogen
bond
ionic
bond
multifunct
deliveri
vehicl
immun
respons
phagocytosi
macrophag
glalg
ngp
investig
raw
macrophag
pharmacokinet
studi
dox
load
glalg
ngp
perform
rat
activ
target
effect
glalg
ngp
studi
hepatocellular
carcinoma
cell
tumorbear
mice
moreov
anticanc
molecular
mechan
doxglalg
ngp
investig
cell
vitro
tumorbear
mice
vivo
result
glalg
ngp
could
avoid
trigger
immunoinflammatori
respons
macrophag
also
decreas
phagocytosi
macrophag
bioavail
dox
increas
time
doxglalg
ngp
free
dox
blood
mice
normal
immun
function
use
construct
tumorbear
mice
instead
nude
mous
also
indic
good
biocompat
ngp
glmediat
alg
ngp
exhibit
excel
hepatocellular
carcinoma
target
effect
vitro
vivo
result
suggest
anticanc
molecular
mechan
combin
therapi
glycyrrhizin
doxorubicin
alg
ngp
perform
via
regul
apoptosi
pathway
ratio
activ
also
verifi
tumorbear
mice
conclus
doxglalg
ngp
could
attenu
activ
macrophag
enhanc
therapeut
efficaci
hepatocellular
carcinoma
result
suggest
combin
therapi
would
provid
new
strategi
liver
cancer
treatment
liver
cancer
second
lead
caus
cancer
mortal
worldwid
caus
death
annual
hepatocellular
carcinoma
hcc
common
histolog
type
liver
ivyspr
intern
publish
cancer
account
case
primari
liver
cancer
nearli
new
case
annual
liver
transplant
chemotherapi
main
treatment
liver
cancer
unavail
liver
donor
major
issu
consid
surgeri
therapeut
efficaci
present
cancer
chemotherapi
limit
narrow
therapeut
index
due
high
nonspecif
toxic
normal
tissu
organ
chemotherapi
drug
usual
nonspecif
small
molecul
poor
pharmacokinet
profil
simpli
distribut
freeli
throughout
bodi
lead
diminish
potenc
actual
target
site
therefor
develop
deliveri
system
alter
chemotherapeut
drug
distribut
vivo
enhanc
deposit
tumor
site
reduc
sideeffect
requir
specif
treatment
cancer
nanocarri
drug
deliveri
system
ndd
nanoparticl
np
paid
attent
last
two
decad
overcom
limit
convent
drug
deliveri
system
cancer
therapi
ndd
provid
advantag
administr
free
drug
includ
target
abil
increas
accumul
tumor
site
enhanc
intracellular
concentr
drug
cancer
cell
avoid
toxic
normal
cell
realiz
control
sustain
releas
enhanc
drug
bioavail
howev
nanoparticl
also
consid
intrud
innat
immun
system
recogn
engulf
macrophag
case
nanoparticl
remov
blood
circul
system
lose
function
quickli
lead
dramat
reduct
effici
diagnost
therapeut
escap
reticularendotheli
system
re
like
macrophag
cell
longer
circul
time
nanoparticl
usual
coat
layer
hydrophil
biocompat
polym
natur
chemic
gain
mani
attent
cancer
therapi
due
safeti
profil
low
toxic
unfortun
antitumor
effect
natur
product
alon
usual
far
satisfactori
glycyrrhizin
gl
figur
main
activ
compon
licoric
multipl
biochem
pharmacolog
activ
includ
antivir
immunoregulatori
antiinflammatori
etc
recent
studi
indic
cardioprotect
effect
high
anticanc
efficaci
hepatocellular
carcinoma
glycyrrhetin
acid
ga
figur
aglycon
gl
also
activ
compon
licoric
previou
studi
show
specif
bind
site
gl
ga
cellular
membran
rat
hepatocyt
grow
interest
focus
gl
gamedi
liver
target
drug
deliveri
system
glmodifi
chitosan
nanoparticl
show
preferenti
accumul
hepatocyt
via
ligandreceptor
interact
previou
studi
indic
gamodifi
nanoparticl
could
perform
liver
target
effect
inhibit
tumor
growth
liver
although
gl
ga
polymerdrug
conjug
construct
target
deliveri
system
show
activ
liver
target
effect
immunoregulatori
antiinflammatori
effect
gl
ga
decreas
dramat
steric
hindranc
effect
moreov
recent
studi
show
inject
glalg
hydrogel
exist
good
biolog
activ
threedimension
cell
cultur
liver
tissu
engin
order
avoid
recogn
engulf
macrophag
cell
preserv
immunoregulatori
effect
gl
studi
gl
introduc
alg
ngp
intermolecular
hydrogen
bond
could
deliv
dox
combin
therapi
suppress
hepat
tumor
growth
subcutan
mous
model
liver
cancer
glalg
ngp
given
prospect
scheme
reduc
phagocytosi
macrophag
ngp
immunoregulatori
activ
gl
ii
increas
bioavail
dox
deliv
dox
specif
bind
site
cellular
membran
hepatocyt
iii
combin
therapi
dox
gl
could
enhanc
anticanc
effici
reduc
cardiotox
free
dox
addit
investig
underli
molecular
mechan
antitumor
effect
combin
therapi
doxglalg
ngp
synthes
phase
invers
temperatur
pit
emulsif
method
report
previous
modif
brief
sodium
algin
solut
wv
obtain
dissolv
sodium
algin
deioniz
water
magnet
stir
h
paraffin
oil
ml
contain
tween
mix
min
stir
rpm
stir
anoth
min
ad
ml
doxorubicin
hydrochlorid
solut
mgml
amount
ml
sodium
algin
solut
drop
ml
paraffin
oil
stir
min
form
uniforms
droplet
ml
solut
wv
contain
glycyrrhizin
ad
stir
gel
h
dox
glalg
ngp
collect
centrifug
lyophil
h
morpholog
examin
perform
transmiss
electron
microscopi
tem
hitachi
japan
ftir
spectra
sampl
record
use
thermo
nicolet
ftir
spectroscopi
thermo
scientif
usa
wave
number
rang
cm
use
kbr
pellet
differenti
scan
calorimetri
dsc
curv
record
use
differenti
scan
calorimet
jade
dsc
perkinelm
corp
wilton
usa
xray
diffract
pattern
dri
sampl
analyz
xrd
analyz
rigaku
tokyo
japan
radiat
nm
gener
kv
xray
sourc
intens
record
rang
particl
size
zeta
potenti
nanogel
particl
determin
dynam
light
scatter
dl
laser
doppler
anemometri
use
zetas
malvern
instrument
uk
room
temperatur
group
analyz
triplic
interact
gl
alg
ca
also
investig
differ
concentr
three
compon
viscoelast
behavior
differ
combin
perform
ar
ex
rheomet
ta
instrument
new
castl
de
usa
chang
conform
secondari
structur
perform
room
temperatur
jasco
spectrophotomet
jasco
corp
tokyo
japan
scheme
schemat
illustr
algin
nanogel
particl
codeliv
glycyrrhizin
doxorubicin
attenu
activ
macrophag
enhanc
therapeut
efficaci
hepatocellular
carcinoma
dox
load
glalg
ngp
separ
ultrafiltr
tube
kda
cut
millipor
corpor
usa
amount
free
dox
filtrat
measur
hplc
equip
kromasil
column
follow
method
chines
pharmacopeia
edit
vitro
releas
profil
dox
nanogel
particl
evalu
use
follow
procedur
two
millilit
nanogel
particl
suspens
transfer
dialysi
membran
bag
molecular
cutoff
kda
bag
immers
ml
pb
incub
appropri
interv
ml
releas
medium
remov
replac
ml
fresh
medium
amount
dox
releas
medium
evalu
hplc
method
murin
macrophag
cell
line
raw
cell
use
investig
immun
respons
macrophag
nanogel
particl
raw
cell
treat
lp
posit
control
variou
concentr
glalg
ngp
calcul
weight
ngp
without
lp
h
atto
phalloidin
dapi
use
stain
cytoskeleton
cell
nuclei
respect
daffm
diacet
use
evalu
intracellular
product
evalu
use
clsm
nitrit
accumul
cultur
medium
measur
indic
product
use
griess
reagent
system
promega
usa
secret
cell
detect
use
mous
elisa
kit
invitrogen
carlsbad
ca
cell
morpholog
also
investig
use
scan
electron
microscopi
sem
quanta
fei
usa
cellular
uptak
cell
alg
ngp
glalg
ngp
evalu
use
rbitc
label
algin
nanogel
particl
accord
protocol
davi
et
al
quantit
determin
cellular
phagocytosi
ngp
perform
flow
cytometri
follow
briefli
cell
incub
rbitcalg
ngp
rbitcglalg
ngp
h
respect
cell
harvest
suspend
ml
pb
contain
paraformaldehyd
pfa
flow
cytometri
analysi
perform
fac
aria
cell
sorter
becton
dickinson
data
mean
fluoresc
signal
obtain
popul
cell
sampl
detect
flow
cytometri
rbitc
excit
wavelength
emiss
wavelength
nm
respect
spraguedawley
sd
rat
intraven
administ
dox
doxglalg
ngp
dose
mgkg
calcul
free
dox
dose
bodi
weight
time
point
min
blood
ml
collect
retroorbit
plexu
rat
anesthesia
transfer
heparinpretr
centrifug
tube
sampl
centrifug
rpm
min
collect
plasma
store
analysi
dox
concentr
determin
accord
publish
literatur
use
hplc
analysi
fluoresc
detector
cell
treat
rbitcalg
ngp
rbitcglalg
ngp
respect
h
cell
incub
dapi
solut
dio
solut
anoth
min
sampl
analyz
three
fluoresc
dye
confoc
laser
scan
microscop
clsm
carl
zeiss
lsm
germani
rbitc
use
observ
ngp
cell
dapi
dio
perform
observ
cell
nucleu
cell
membran
respect
quantit
determin
cellular
phagocytosi
ngp
perform
flow
cytometri
follow
briefli
cell
incub
rbitcalg
ngp
rbitcglalg
ngp
h
respect
cell
harvest
suspend
ml
pb
contain
paraformaldehyd
pfa
flow
cytometri
analysi
perform
fac
aria
cell
sorter
becton
dickinson
data
mean
fluoresc
signal
obtain
popul
cell
sampl
detect
flow
cytometri
rbitc
excit
wavelength
emiss
wavelength
nm
respect
viabil
detect
calceinam
pi
detect
cell
treat
alg
ngp
glalg
ngp
h
medium
discard
cell
incub
calceinam
pi
min
firstli
analyz
use
clsm
cell
cultur
alg
ngp
glalg
ngp
h
phenol
red
free
dmem
collect
determin
ldh
accord
protocol
mtt
ad
final
concentr
mgml
dmem
incub
addit
h
cultur
medium
discard
formazan
precipit
solubil
dmso
absorb
measur
nm
multifunct
micropl
reader
flexstat
molecular
devic
usa
kunm
mice
origin
swiss
mice
exhibit
minim
variat
growth
reproduct
perform
wide
use
mous
type
biolog
pharmacolog
studi
china
especi
immunolog
research
tumorbear
mice
model
tissu
distribut
nanogel
particl
investig
rbitcalg
ngp
rbitcglalg
ngp
normal
kunm
mice
hepatocarcinoma
tumorbear
mice
intraven
administ
rbitcalg
ngp
rbitcglalg
ngp
heart
liver
spleen
lung
kidney
tumor
remov
differ
time
point
h
observ
cri
fluoresc
imag
system
maestro
cri
usa
cell
viabil
cytotox
enzym
activ
assay
dox
glalg
ngp
cell
treat
dox
doxglalg
ngp
ngp
contain
equal
amount
dox
respect
h
viabil
cytotox
caspas
activ
event
detect
within
sampl
promega
triplex
assay
kit
madison
wisconsin
usa
cell
collect
total
rna
cell
isol
use
sangon
column
trizol
total
rna
extract
kit
accord
manufactur
instruct
realtim
rtpcr
primer
shown
tabl
reaction
setup
follow
faststart
univers
sybr
green
master
rox
roch
germani
abi
prism
realtim
pcr
system
fold
increas
decreas
determin
rel
blank
control
normal
housekeep
gene
use
method
protein
express
bax
bclxl
analyz
western
blot
cell
collect
centrifug
resuspend
extract
buffer
mammalian
protein
extract
kit
sangon
china
cell
debri
remov
centrifug
supernat
collect
detect
protein
concentr
bca
method
pierc
usa
amount
mg
cellular
protein
electroblot
onto
pvdf
membran
follow
separ
sdspolyacrylamid
gel
electrophoresi
pvdf
membran
transfer
incub
block
solut
skim
milk
hour
room
temperatur
incub
overnight
dilut
antibax
antibclxl
antibodi
blot
wash
five
time
tween
salin
ttb
incub
dilut
horseradish
peroxidaseconjug
secondari
antibodi
h
room
temperatur
blot
wash
five
time
ttb
develop
horseradish
peroxidas
substrat
millipor
corpor
usa
data
captur
exposur
kodak
biomax
light
film
tumor
growth
inhibitori
activ
dox
glalg
ngp
assess
mice
bear
liver
tumor
liver
tumor
model
establish
accord
techniqu
report
shi
et
al
briefli
kunm
mice
normal
immun
system
inject
subcutan
right
limb
armpit
ml
cell
suspens
contain
cell
ten
day
tumor
inocul
mice
divid
six
group
n
intraven
administ
salin
control
alg
ngp
glalg
ngp
dox
mgkg
doxalg
ngp
mgkg
calcul
free
dox
dose
doxglalg
ngp
mgkg
calcul
free
dox
dose
volum
ml
bodi
weight
mice
measur
daili
tumor
volum
mous
monitor
tumor
volum
calcul
follow
tumor
volum
mm
width
antitumor
activ
evalu
term
tumor
weight
g
volum
mm
time
sacrific
tumor
liver
heart
remov
fix
neutral
formalin
fix
tissu
dehydr
embed
paraffin
section
stain
hematoxylin
eosin
h
e
stain
section
test
sampl
examin
use
light
microscopi
olympu
japan
slide
tumor
deparaffin
rehydr
immunofluorescencestain
use
pcna
antibodi
immunofluoresc
detect
kit
sangon
biotech
co
ltd
shanghai
china
tunel
assay
kit
beyotim
biotech
shanghai
china
accord
manufactur
instruct
valu
repres
mean
exclud
result
given
pharmacokinet
studi
rat
express
mean
se
statist
analysi
perform
origin
pro
softwar
student
ttest
oneway
anova
valu
p
p
consid
statist
signific
ngp
fabric
intermolecular
hydrogen
bond
glycyrrhizin
algin
ionic
bond
algin
calcium
figur
verifi
differ
storag
modulu
g
valu
figur
ionic
bond
ca
ion
carboxyl
acid
group
alg
play
vital
role
nanogel
format
intermolecular
hydrogen
bond
gl
alg
moreov
conform
structur
alg
chang
addit
gl
calcium
suggest
effect
intermolecular
hydrogen
bond
glycyrrhizin
algin
ionic
bond
algin
calcium
figur
interact
identifi
data
ftir
xrd
dsc
shown
figur
g
ftir
data
show
thatoh
characterist
peak
cm
gl
shift
cm
glalg
ngp
figur
suggest
interact
gl
alg
ngp
prepar
characterist
diffract
peak
gl
disappear
format
glalg
ngp
figur
also
suggest
interact
gl
alg
phenomenon
found
dsc
data
figur
glalg
ngp
spheric
uniformli
distribut
tem
particl
size
approxim
nm
figur
zeta
potenti
key
factor
evalu
stabil
colloid
dispers
neg
surfac
charg
nanoparticl
could
reduc
plasma
protein
bioadhes
low
rate
nonspecif
cellular
uptak
due
carboxyl
group
alg
doxglalg
ngp
strongli
neg
surfac
charg
mv
remain
virtual
unchang
load
drug
compar
blank
glalg
ngp
investig
feasibl
glalg
ngp
drug
carrier
dox
model
drug
encapsul
glalg
ngp
drugload
capac
encapsul
effici
tumor
tissu
acid
environ
normal
physiolog
condit
phosphatebuff
salin
pb
solut
ph
valu
chosen
investig
releas
profil
dox
load
glalg
ngp
figur
total
amount
dox
releas
glalg
ngp
ph
ph
respect
may
due
proton
amino
group
acid
ph
lower
amount
dox
releas
blood
transport
target
site
abund
drug
could
releas
reach
lesion
site
enter
cell
mimick
microenviron
endosom
lysosom
via
receptormedi
endocytosi
glalg
ngp
phrespons
could
enhanc
therapeut
efficaci
lesion
site
reduc
sideeffect
drug
normal
organ
macrophag
play
import
role
host
defens
releas
factor
prostaglandin
mediat
cytokin
involv
immun
respons
could
recruit
macrophag
remov
foreign
substanc
bodi
raw
cell
one
kind
mous
macrophag
cell
line
usual
chosen
investig
respons
nanoparticl
innat
immun
system
lp
one
power
activ
macrophag
use
posit
control
studi
sem
imag
depict
cell
morpholog
obtain
figur
control
group
cell
observ
normal
state
exhibit
roundshap
morpholog
cell
morpholog
mean
diamet
chang
dramat
lp
stimul
mani
cell
exhibit
spread
morpholog
repres
activ
state
cell
treat
glalg
ngp
shown
almost
invari
round
shape
fewer
cell
exhibit
deform
morpholog
mean
diamet
cell
almost
similar
control
group
recogn
mediat
regul
inflammatori
respons
high
amount
product
activ
inflammatori
cell
shown
figur
intracellular
product
label
daffm
diacet
suggest
strong
fluoresc
intens
observ
lp
treatment
almost
fluoresc
observ
treat
glalg
ngp
concentr
nitrit
accumul
cultur
medium
estim
index
secretori
product
lp
could
induc
product
significantli
compar
control
group
differ
concentr
glalg
ngp
effect
induc
product
ns
compar
control
group
figur
immun
inflamm
progress
seri
cytokin
mediat
contribut
evoc
regress
immun
respons
critic
cytokin
involv
immun
inflamm
progress
lp
treatment
significantli
induc
higher
secret
level
control
group
differ
posit
control
lp
high
activ
glalg
ngp
treat
cell
show
littl
activ
ns
compar
control
group
figur
fluoresc
label
nanoparticl
provid
rapid
simpl
sensit
mean
quantifi
cellassoci
nanoparticl
studi
algin
label
rbitc
fluoresc
probe
observ
cellular
phagocytosi
raw
cell
nanogel
particl
phagocytosi
raw
cell
nanogel
particl
quantifi
via
flow
cytometri
shown
figur
effici
cellular
uptak
reduc
significantli
introduct
gl
alg
ngp
differ
time
point
result
suggest
glmediat
alg
ngp
could
reduc
phagocytosi
raw
cell
vitro
would
play
import
role
increas
long
circul
vivo
although
nanobas
drug
deliveri
system
produc
advanc
cancer
therapi
rapid
elimin
nanoparticl
bodi
suggest
common
problem
appli
particl
vivo
applic
absorpt
plasma
protein
nonspecif
uptak
reticularendotheli
system
re
like
macrophag
cell
particl
remov
blood
circul
system
quickli
lead
dramat
decreas
effici
nanoparticlebas
diagnost
therapeut
reduc
uptak
nanoparticl
macrophag
cell
mani
attempt
perform
control
physicochem
characterist
particl
dox
blood
concentrationtim
profil
show
biphas
curv
first
rapid
distribut
phase
follow
slow
elimin
phase
figur
blood
concentr
dox
load
glalg
ngp
significantli
higher
free
dox
p
distribut
phase
also
signific
differ
dox
load
glalg
ngp
free
dox
elimin
phase
main
pharmacokinet
paramet
calcul
use
bicompartment
pharmacokinet
analysi
summar
tabl
distribut
halflif
dox
load
glalg
ngp
higher
free
dox
tabl
p
halflif
dox
load
glalg
ngp
increas
fold
comparison
free
dox
increas
blood
circul
time
dox
load
glalg
ngp
also
evidenc
increas
auc
valu
decreas
total
clearanc
cl
comparison
free
dox
tabl
p
auc
auc
valu
free
dox
mgl
h
mgl
h
dox
load
glalg
ngp
mgl
h
mgl
h
demonstr
long
circul
properti
glalg
ngp
volum
distribut
vd
dox
load
glalg
ngp
significantli
smaller
free
dox
p
show
less
extens
distribut
dox
tissu
administ
dox
load
glalg
ngp
order
investig
long
circul
nanogel
particl
introduc
gl
compar
chang
kinet
circul
doxglalg
ngp
doxalg
ngp
figur
distribut
halflif
dox
load
glalg
ngp
higher
dox
load
alg
ngp
auc
valu
dox
load
glalg
ngp
increas
fold
compar
dox
load
alg
ngp
respect
result
indic
alg
ngp
introduc
gl
attenu
rapid
uptak
macrophag
phagocytosi
bloodstream
prolong
retent
period
dox
system
circul
investig
cellular
uptak
cell
glalg
ngp
first
detect
cell
viabil
glalg
ngp
cell
fluoresc
imag
mtt
ldh
assay
fluoresc
assay
use
calceinam
pi
show
differ
concentr
glalg
ngp
affect
cell
viabil
compar
control
group
figur
secret
ldh
indic
cytotox
sinc
integr
cell
membran
destroy
apoptosi
necrosi
cell
product
ldh
increas
glalg
ngp
group
compar
control
group
figur
cell
viabil
cell
also
confirm
mtt
assay
figur
result
suggest
glalg
ngp
safe
liver
drug
deliveri
order
investig
whether
uptak
nanogel
particl
cell
receptormedi
depend
incub
nanogel
particl
cell
incub
cell
rbitcalg
ngp
h
littl
intracellular
fluoresc
observ
cell
endocytosi
inhibit
cellular
uptak
nanogel
particl
energydepend
howev
strong
intracellular
fluoresc
observ
cell
treat
rbitcglalg
ngp
figur
due
abund
receptor
hepatocyt
membran
gl
improv
cellular
uptak
nanogel
particl
activ
target
effect
without
energydepend
moreov
vari
cultur
condit
weak
intracellular
fluoresc
could
observ
cell
treatment
rbitcalg
ngp
suggest
passiv
endocytosi
rbitcalg
ngp
rare
tendenc
chang
introduct
gl
alg
ngp
stronger
intracellular
fluoresc
observ
cell
compar
treatment
rbitcalg
ngp
intens
cellular
uptak
combin
passiv
endocytosi
activ
target
effect
activ
target
effect
play
lead
role
phagocytosi
phagocytosi
cell
nanogel
particl
quantifi
via
flow
cytometri
shown
figur
effici
cellular
uptak
enhanc
time
introduct
gl
alg
ngp
time
goe
rbitcglalg
ngp
rbitcalg
ngp
observ
cell
h
moreov
investig
normal
cell
cultur
condit
passiv
endocytosi
glmediat
receptor
target
effect
work
togeth
uptak
nanogel
particl
effici
cellular
uptak
still
enhanc
time
rbitcglalg
ngp
compar
rbitcalg
ngp
h
result
suggest
glmediat
activ
target
play
lead
role
cellular
uptak
nanogel
particl
vitro
evalu
nanoparticl
efficaci
anim
model
must
chosen
immun
statu
similar
actual
diseas
firstli
investig
activ
target
effect
nanogel
particl
kunm
mice
normal
immun
system
fluoresc
intens
nanogel
particl
differ
tissu
shown
figur
h
inject
rbitcalg
ngp
rbitcglalg
ngp
strongest
fluoresc
intens
found
liver
kidney
fluoresc
intens
glalg
ngp
twice
much
alg
ngp
liver
even
h
might
activ
target
effect
gl
alg
ngp
result
accumul
alg
ngp
liver
figur
secondli
investig
whether
target
effect
ngp
tumor
rbitcalg
rbitcglalg
ngp
inject
tail
vein
tumorbear
mice
could
close
clinic
symptom
rather
balbc
nude
mice
immun
defici
result
fluoresc
analysi
show
glalg
ngp
assembl
tumor
alg
ngp
figur
rbitcalg
rbitcglalg
ngp
inject
tumorbear
mice
rbitcglalg
ngp
accumul
tumor
rbitcalg
ngp
tumorbear
mice
led
less
rbitcglalg
ngp
accumul
liver
reason
seem
like
differ
liver
accumul
rbitcglalg
ngp
vs
rbitcalg
ngp
time
especi
h
inject
accumul
effici
glalg
ngp
tumor
almost
time
alg
ngp
furthermor
total
fluoresc
intens
increas
significantli
glalg
ngp
inject
compar
alg
ngp
inject
differ
point
liver
tumor
p
compar
alg
ngp
tissu
show
weaker
fluoresc
intens
surfac
liver
hepatoma
cell
exist
lot
gl
receptor
introduc
glmediat
liver
hepatoma
celltarget
drug
deliveri
system
rbitcglalg
ngp
inject
glmediat
activ
target
effect
liver
hepatoma
cell
target
effect
result
nanogel
liver
tumor
site
thu
auc
rbitcglalg
ngp
greater
rbitcalg
nanoparticl
similarli
total
fluoresc
intens
increas
significantli
glalg
ngp
inject
compar
alg
ngp
inject
differ
point
liver
tumor
fluoresc
intens
decreas
metabol
kidney
littl
fluoresc
intens
observ
h
ngp
inject
indic
prepar
glalg
ngp
exhibit
good
liver
target
abil
due
passiv
target
via
enhanc
permeabl
retent
effect
activ
target
abil
gl
cytotox
detect
triplex
assay
promega
usa
combin
three
assay
chemistri
assess
viabil
cytotox
caspas
activ
event
within
singl
assay
well
dox
doxglalg
ngp
ngp
contain
equal
amount
dox
respect
could
decreas
viabil
increas
toxic
hepatoma
cell
significantli
control
group
p
moreov
compar
free
dox
doxglalg
ngp
decreas
viabil
increas
toxic
hepatoma
cell
significantli
p
p
figur
interest
doxglalg
ngp
show
increas
cytostat
activ
comparison
free
dox
sinc
less
dox
releas
ngp
ph
within
h
involv
pglycoprotein
might
restrict
transport
free
dox
could
pump
cell
pglycoprotein
substrat
previou
studi
suggest
doxcontain
anion
liposom
nanoparticl
could
inhibit
pglycoprotein
activ
vehicl
particularli
indic
drugresist
tumor
receptormedi
drug
target
effect
gl
alg
ngp
glalg
ngp
could
aggreg
endosom
releas
drug
reduc
efflux
effect
pglycoprotein
enhanc
drug
efficaci
cytotox
hepatoma
cell
caspas
famili
play
import
role
regul
apoptosi
activ
caspas
symbol
apoptosi
induct
respons
deathinduc
signal
origin
mitochondria
endoplasm
reticulum
effector
caspas
level
activ
play
import
role
deathreceptor
mitochondri
pathway
use
extens
respons
extracellular
intracellular
stimulu
induc
apoptosi
mrna
express
upregul
significantli
glalg
ngp
dox
doxglalg
ngp
compar
control
group
p
p
figur
glalg
ngp
without
dox
dox
doxglalg
ngp
higher
effici
activ
control
group
p
figur
although
less
free
dox
releas
ngp
within
h
activ
increas
time
doxglalg
ngp
dox
group
one
import
antiapoptot
member
famili
bind
proapoptot
protein
bax
x
protein
protect
cell
apoptosi
maintain
integr
mitochondri
membran
bax
releas
antiapoptot
counterpart
caus
cell
death
activ
thu
balanc
famili
member
crucial
apoptot
trigger
antiapoptot
protein
famili
valid
drug
target
cancer
treatment
shown
figur
cd
mrna
express
bax
upregul
significantli
glalg
ngp
dox
doxglalg
ngp
wherea
downregul
significantli
compar
control
group
effect
greatli
increas
ratio
proapoptot
bax
antiapoptot
messeng
p
figur
western
blot
analysi
figur
f
cell
treat
dox
doxglalg
ngp
indic
protein
express
bax
increas
significantli
compar
control
group
concentrationdepend
manner
p
p
also
signific
differ
glalg
ngp
control
group
p
contrast
consider
decreas
protein
level
observ
result
signific
increas
ratio
glalg
ngp
dox
doxglalg
ngpstreat
cell
compar
control
group
higher
doxglalg
ngp
concentr
free
dox
p
consist
correspond
chang
observ
mrna
express
furthermor
mrna
protein
express
bclxl
also
investig
result
show
mrna
express
bclxl
downregul
significantli
howev
protein
express
downregul
glalg
ngp
dox
doxglalg
ngp
significantli
comparison
control
group
figur
report
indic
augment
ratio
might
contribut
apoptosi
via
caspas
activ
mitochondria
pathway
studi
reveal
express
significantli
inhibit
bax
express
rel
constant
suggest
doxglalg
ngp
induc
apoptosi
shift
ratio
favor
apoptosi
vivo
antitumor
activ
alg
ngp
glalg
ngp
dox
dose
mg
doxkg
bodi
weight
doxalg
ngp
dose
mg
dox
load
alg
ngpskg
bodi
weight
doxglalg
ngp
dose
mg
dox
load
glalg
ngpskg
bodi
weight
evalu
kunm
mice
bear
liver
tumor
figur
repres
photograph
excis
liver
tumor
provid
addit
direct
visual
represent
tumorsuppress
effect
figur
tumor
growth
inhibit
base
tumor
volum
signific
treatment
dox
mgkg
doxalg
ngp
mgkg
dox
glalg
ngp
mgkg
day
respect
figur
worth
note
glalg
ngp
also
could
inhibit
tumor
growth
significantli
compar
treatment
normal
salin
p
among
three
drug
administr
group
doxglalg
ngp
exhibit
greater
antitumor
effect
free
dox
doxalg
ngp
multidrug
resist
often
associ
atpdepend
decreas
cellular
drug
accumul
overexpress
certain
atpbind
cassett
transport
protein
abc
tumor
cell
multidrug
resist
protein
one
abc
protein
express
tissu
import
absorpt
eg
lung
gut
metabol
elimin
liver
kidney
furthermor
previou
studi
reveal
mrna
express
increas
hepatocellular
carcinoma
compar
surround
tissu
dox
substrat
glycyrrhizin
inhibitor
therefor
gl
alg
ngp
could
inhibit
activ
dox
could
deliv
tumor
tissu
chang
bodi
weight
mice
import
index
evalu
system
toxic
variat
bodi
weight
mice
shown
figur
mice
treat
dox
display
obviou
bodi
weight
reduct
suggest
toxic
effect
anim
bodi
weight
mice
glalg
ngp
group
differ
greatli
salin
indic
glalg
ngp
exhibit
sever
system
toxic
contrast
bodi
weight
loss
revers
doxglalg
ngp
mgkg
compar
free
dox
mgkg
group
suggest
glalg
ngp
could
reduc
system
toxic
longterm
applic
histolog
stain
morpholog
chang
tumor
shown
figur
normal
salin
group
tumor
cell
histiocytoid
shape
arrang
tightli
nucleu
tumor
cell
larg
appar
common
characterist
cell
indic
success
establish
liver
tumor
model
howev
glalg
ngp
group
dox
group
doxalg
ngp
doxglalg
ngp
group
proport
tumor
area
reduc
tumor
cell
arrang
loos
surround
normal
cell
lightli
stain
condens
nuclei
indic
growth
liver
tumor
inhibit
next
investig
tumor
cell
growth
activ
use
prolifer
cell
nuclear
antigen
pcna
stain
stain
day
treatment
figur
high
fluoresc
intens
pcna
posit
tumor
cell
indic
high
prolifer
abil
compar
salin
treatment
free
dox
doxalg
ngp
doxglalg
ngp
exhibit
lower
posit
tumor
cell
weaker
fluoresc
intens
hand
tunel
appli
examin
apoptot
statu
tumor
cell
figur
inject
free
dox
doxalg
ngp
doxglalg
ngp
remark
increas
tunelposit
tumor
cell
compar
salin
treatment
doxglalg
ngp
exhibit
strongest
fluoresc
intens
free
dox
doxalg
ngp
doxglalg
ngp
could
inhibit
growth
activ
tumor
cell
promot
apoptot
tumor
cell
enhanc
antitumor
effect
therapeut
potenti
dox
restrict
toxic
side
effect
mainli
cardiotox
result
narrow
therapeut
index
due
high
toxic
healthi
tissu
reduct
drug
side
effect
still
one
major
concern
develop
novel
drug
deliveri
carrier
system
heart
normal
salin
group
exhibit
normal
myocardium
architectur
cell
distribut
similarli
glalg
ngp
group
histopatholog
featur
observ
heart
tissu
applic
free
dox
myofibrillar
loss
inflammatori
cell
infiltr
black
arrow
observ
indic
obviou
cardiotox
contrast
dox
group
littl
histopatholog
featur
observ
doxalg
ngp
obviou
histopatholog
abnorm
observ
follow
treatment
doxglalg
ngp
mgkg
indic
doxglalg
ngp
deliveri
system
avoid
cardiotox
induc
free
dox
report
show
glycyrrhizin
could
allevi
rat
myocardi
irinduc
injuri
via
block
phosphojnkbax
pathway
one
reason
doxglalg
ngp
could
perform
target
deliveri
dox
tumor
decreas
accumul
dox
heart
avoid
cardiotox
reason
might
glycyrrhizin
releas
nanogel
particl
perform
myocardi
protect
proven
combin
administr
solubl
gl
along
dox
compar
free
dox
gl
could
reduc
cardiotox
induc
free
dox
figur
furthermor
hepatotox
nanogel
particl
also
investig
shown
figur
free
dox
treatment
result
hepat
damag
includ
macroand
microvesicular
steatosi
bile
stasi
histopatholog
featur
observ
group
investig
hepatotox
liver
enzym
level
alt
ast
also
detect
level
alt
ast
increas
significantli
free
dox
treatment
compar
salin
treatment
doxglalg
ngp
could
decreas
hepatotox
induc
dox
result
suggest
doxglalg
ngp
safe
target
treatment
hepatocellular
carcinoma
ndd
cancer
therapi
consid
intrud
innat
immun
system
could
readili
recogn
engulf
macrophag
cell
studi
glycyrrhizin
mediat
nanogel
particl
could
avoid
activ
innat
immun
system
phagocytosi
macrophag
prolong
blood
circul
system
gl
one
drug
load
alg
ngp
could
particip
construct
ngp
intermolecular
hydrogen
bond
gl
alg
furthermor
bioavail
dox
improv
significantli
glalg
ngp
free
dox
mice
normal
immun
function
use
construct
tumorbear
mice
instead
nude
mice
immunodefici
also
indic
good
biocompat
ngp
combin
therapi
dox
gl
alg
ngp
increas
activ
target
effect
tumor
therapi
exert
signific
antitumor
effect
via
regul
apoptosi
pathway
moreov
decreas
cardiotox
free
dox
cardioprotect
effect
gl
result
would
provid
new
strategi
combin
therapi
natur
product
chemotherapeut
drug
cancer
especi
liver
cancer
ndd
nanocarri
drug
deliveri
system
ngp
nanogel
particl
hcc
hepatocellular
carcinoma
re
reticularendotheli
system
human
hepatocellular
carcinoma
pit
phase
invers
temperatur
dsc
differenti
scan
calorimetri
abc
atpbind
cassett
transport
protein
multidrug
resist
protein
